FAQ

1. What is translational research?

Translational research transforms currently available knowledge into useful measures for everyday clinical and public health practice. Translation research aims to assess implementation of standards of care, understand the barriers to their implementation, and intervene throughout all levels of health care delivery and public health to improve quality of care and health outcomes, including quality of life. (from Narayan et al. “Diabetes Translation Research: Where Are We and Where Do We Want To Be?” in Ann Intern Med, 2004; 140:958-963). 

2. What type of projects does BRIDGES support?

BRIDGES supports 2 types of projects:

  • Short-term projects for a maximum duration of 2 years and a maximum amount of USD 65,000.
  • Long term projects for a maximum duration of 3 years and a maximum amount of USD 400,000.

3. What should the budget for each project include?

The budget for each project submitted must include both the direct and indirect costs (ie. overhead costs including the financial audit).

4. Can the purchase of drugs (eg. insulinosensitizers or anoxerigens) be included in the budget?

No, the purchase of drugs may not be included in the budget.

5. How should salaries be accounted for in the budget?

Only salaries directly linked to the project can be included in the direct costs (for example, the salary of the principal investigator can be included in the direct costs). The salary of a person dedicating a limited amount of time to the project (eg. the accountant of the institution dedicating 5% of his/her time) will be included in the overhead costs.

6. What are the criteria for selection?

The Review Committee will focus on the following criteria when considering an application:

  • Programme objectives
  • Significance of the research to the wider diabetes community
  • Investigator qualifications and demonstration of competence for conducting work in the area
  • Appropriate facilities and operational infrastructure to conduct the proposed project
  • Demonstration of appropriate project financial management
  • Participants welfare/ethical approval and practice/potential benefits for the participants

7. In what currency will the grants be allocated?

All grants will be allocated in US Dollars.

8. Is it necessary to have completed a short-term grant in order to apply for a long-term grant?

No, a project does not have to have succesfully completed a short-term grant to apply for a long-term grant.

9. What is a financial audit?

A financial audit, or more accurately, an audit of financial statements, is the examination by an independent third party of the financial statements of a company or of any other legal entity (including governments) resulting in the publication of an independent opinion on whether or not those financial statements are relevant, accurate, complete and fairly presented. Financial audits are typically performed by firms of practising accountants due to the specialist financial reporting knowledge they require. The financial audit of the project must be realized by:

  • An external auditing firm with all the necessary national accreditation(s)
  • An internal auditing department providing that this department acts independently and with all the necessary national accreditation(s)

Upon termination of the grant period, each selected project is required to send a financial audit for approval. The cost linked to the financial audit must be included in the original budget proposed to the BRIDGES Review Committee. The final installment of 10% will be delivered within 60 days of reception and acceptance by the BRIDGES Executive Office of the final report and the financial audit.

10. Are project applications limited to specific locations?

No. The International Diabetes Federation represents more than 220 associations in more than 160 countries. Therefore applications from all over the world are encouraged.

11. Are letters of reference required when submitting an application?

Yes. When applying for a BRIDGES grant, each applicant is requested to provide 2 letters of reference. Ideally, one should be dedicated to the institution/organization, the other to the main investigator. For the letter of intent, the letter of reference concerning the main investigator is not requested.

12. Can an institution/organization subit more than one application?

Yes, an institution may submit more than one application. However, each project must be independent and not related to any of the other projects submitted by the institution.

13. When are the next round of funding?

The fourth round of funding will begin in May 2011 and will end in February 2012. It will be dedicated to short term projects.

14. What is the involvement of Lilly Diabetes in BRIDGES?

BRIDGES is supported by an educational grant from Lilly Diabetes. Lilly Diabetes does not have privileged access to applications or to funded projects. Any results, including data and intellectual property rights, from funded projects will become the property of the International Diabetes Federation, which will put them in the public domain to the extent permitted by applicable data protection and privacy laws.

Lilly Diabetes has one representative, as an observer with no voting rights, in the Executive Committee of BRIDGES and no representative in the Review Committee. Lilly Diabetes is not informed of the composition of the Review Committee.

15. Can a project be submitted in successive rounds of funding?

Yes, applicants are allowed to make successive applications in subsequent rounds of grant funding. If a project is not initially selected, the Review Committee will make comments as to the rationale for non-selection and provide recommendations for improvements on the application.